| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +2.83% | +8.10% | +63.42% | +123.50% | 1,133B | |
| +3.81% | +5.40% | +39.47% | +74.91% | 621B | |
| +0.14% | +0.60% | +23.25% | +95.03% | 503B | |
| +0.03% | +5.72% | +39.64% | +64.06% | 379B | |
| -1.76% | -0.09% | +68.04% | +43.41% | 370B | |
| +1.58% | +5.07% | +23.26% | +51.98% | 292B | |
| +2.90% | +5.53% | +4.06% | +24.45% | 262B | |
| +2.04% | +4.97% | +48.53% | +60.42% | 237B | |
| +2.36% | +2.38% | +26.68% | +102.04% | 190B | |
| Average | +1.37% | +3.22% | +37.37% | +71.09% | 443.11B | |
| Weighted average by Cap. | +1.81% | +3.73% | +43.30% | +82.74% |
Employees
4
Sector
Pharmaceuticals
